-+ 0.00%
-+ 0.00%
-+ 0.00%

ALT5 To Separate Into Two Independent Publicly Traded Companies

Benzinga·10/02/2024 12:35:56
Listen to the news

Following consummation of this plan, ALT5 will execute the separation of its Fintech and Biotech businesses, with ALT5 continuing as a leading fintech organization post-separation. The Biotech segment will emerge as Alyea Therapeutics Corporation, an independent firm dedicated to developing non-addictive pain management therapies. Upon separation, each company will present its own unique growth opportunities.